SB208 for the Treatment of Tinea Pedis

• Status: Completed
• Trial end date: 2017-02-01
• Target enrollment: 0
• Participant gender: All

Summary

This is a phase 2, multi-center, double-blind, randomized, vehicle-controlled study to be conducted in non immunocompromised adult subjects with interdigital tinea pedis.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Novan, Inc.

Criteria

Inclusion Criteria:

• Otherwise healthy male and female subjects with clinical diagnosis of interdigital t. pedis

• T.pedis provisionally confirmed at baseline by a positive KOH wet mount for segmented fungal hyphae on skin scraping from the target site

Exclusion Criteria:

• Women who are pregnant or nursing or planning on becoming pregnant

• Subjects with onychomycosis or moccasin-type t. pedis

• Subjects using topical or systemic anti-fungal agents